Current Value
$725.701 Year Return
Current Value
$725.701 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IHE | 74.75% | $562.13M | 0.39% |
PPH | 68.32% | $621.67M | 0.36% |
IXJ | 61.24% | $3.87B | 0.41% |
IYH | 60.29% | $2.85B | 0.39% |
VHT | 59.23% | $15.34B | 0.09% |
XLV | 59.07% | $35.70B | 0.09% |
FHLC | 59.01% | $2.49B | 0.084% |
PINK | 51.61% | $134.87M | 0.5% |
XPH | 47.38% | $139.13M | 0.35% |
DUHP | 47.27% | $8.01B | 0.21% |
BBH | 47.19% | $333.72M | 0.35% |
PTH | 46.81% | $99.62M | 0.6% |
IBB | 46.55% | $5.37B | 0.45% |
QUAL | 45.10% | $50.54B | 0.15% |
FXH | 44.46% | $903.50M | 0.62% |
QUS | 44.09% | $1.49B | 0.15% |
FBT | 44.01% | $1.02B | 0.56% |
BBLU | 43.90% | $255.22M | 0.15% |
IHI | 43.69% | $4.65B | 0.4% |
XBI | 43.48% | $5.05B | 0.35% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTI | 0.02% | $995.39M | 0.07% |
TFLO | 0.13% | $7.09B | 0.15% |
IEI | -0.15% | $16.09B | 0.15% |
IBTH | -0.28% | $1.52B | 0.07% |
BILS | -0.42% | $3.97B | 0.1356% |
IBMR | 0.50% | $236.02M | 0.18% |
SCHR | 0.61% | $10.52B | 0.03% |
IBTJ | -0.66% | $658.04M | 0.07% |
VGIT | 0.67% | $31.35B | 0.04% |
BILZ | -0.85% | $880.81M | 0.14% |
IBTK | 0.86% | $431.61M | 0.07% |
ASHR | 0.91% | $1.95B | 0.65% |
TYA | 0.91% | $150.15M | 0.15% |
SPTI | 0.94% | $8.63B | 0.03% |
BWX | -0.94% | $1.41B | 0.35% |
CNYA | 1.33% | $221.60M | 0.6% |
SHYM | -1.52% | $322.98M | 0.35% |
CORN | -1.60% | $50.03M | 0.2% |
UGA | 1.62% | $72.35M | 0.97% |
CANE | 1.72% | $10.43M | 0.29% |
SeekingAlpha
BlackRock Capital Appreciation V.I. Fund posted a return of -10.69% (Class I shares) for the first quarter of 2025. Read more here.
SeekingAlpha
Does Anavex's Alzheimer's Drug Actually Confer Benefit?
SeekingAlpha
INmune Bio: XPro Trial Readout In Alzheimer's Disease Offers Big Opportunity
MarketWatch
Eli Lilly & Co. stock outperforms competitors on strong trading day
Finnhub
May 15 - Rznomics: * RZNOMICS ENTERS GLOBAL LICENSING AGREEMENT WITH ELI LILLYFORRNA-EDITING THERAPEUTICS * RZNOMICS: UPFRONT PAYMENT WAS NOT DISCLOSED ...
SeekingAlpha
Eli Lilly and Company (NYSE:LLY) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ETCompany ParticipantsLucas Montarce - CFOMike...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
COST | 45.94% | $439.93B | +25.98% | 0.48% |
AZN | 44.18% | $205.40B | -13.95% | 2.30% |
EQIX | 43.63% | $84.05B | +6.12% | 2.03% |
NVO | 42.87% | $216.81B | -52.17% | 2.54% |
REGN | 41.91% | $61.69B | -41.59% | 0.00% |
SPGI | 41.27% | $157.01B | +17.50% | 0.72% |
BSX | 41.23% | $152.31B | +38.28% | 0.00% |
GEHC | 40.99% | $33.35B | -11.07% | 0.18% |
ALC | 40.76% | $43.15B | -3.03% | 0.68% |
FOLD | 40.49% | $1.81B | -39.13% | 0.00% |
MCO | 40.31% | $86.18B | +16.87% | 0.73% |
AVB | 39.91% | $28.70B | +1.58% | 3.39% |
SKT | 38.84% | $3.44B | +7.35% | 3.70% |
ECL | 38.59% | $70.92B | +7.38% | 0.97% |
ISRG | 38.48% | $202.84B | +41.70% | 0.00% |
AMRX | 38.27% | $2.30B | +6.99% | 0.00% |
HROW | 37.77% | $922.08M | +57.77% | 0.00% |
CPRX | 37.76% | $2.85B | +40.46% | 0.00% |
SYK | 37.59% | $147.64B | +16.36% | 0.84% |
TRI | 37.52% | $83.39B | +9.02% | 0.90% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SCHL | -<0.01% | $463.86M | -51.40% | 4.58% |
HUSA | 0.02% | $10.59M | -51.78% | 0.00% |
ACIC | 0.02% | $532.37M | -8.52% | 0.00% |
HTO | -0.03% | $1.71B | -14.85% | 3.24% |
MED | -0.07% | $140.14M | -49.72% | 0.00% |
CMTG | -0.08% | $341.44M | -71.18% | 14.34% |
ZYXI | 0.11% | $63.50M | -80.93% | 0.00% |
KLG | 0.12% | $1.49B | -17.13% | 3.71% |
MVO | 0.12% | $67.51M | -39.23% | 21.45% |
CNH | -0.13% | $16.65B | +12.58% | 0.00% |
CVS | 0.14% | $75.95B | +6.72% | 4.44% |
OIS | -0.15% | $295.73M | +3.69% | 0.00% |
BZUN | 0.15% | $183.01M | +9.68% | 0.00% |
PARR | -0.16% | $1.00B | -30.40% | 0.00% |
OXBR | -0.17% | $14.96M | +27.20% | 0.00% |
GPRE | -0.21% | $335.50M | -73.03% | 0.00% |
RRGB | 0.22% | $53.74M | -57.87% | 0.00% |
GALT | 0.23% | $82.13M | -57.52% | 0.00% |
CTBI | 0.23% | $954.26M | +19.75% | 3.54% |
MNRO | -0.24% | $388.74M | -53.48% | 8.66% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -37.36% | $102.66M | 0.85% |
TAIL | -37.25% | $145.16M | 0.59% |
TPMN | -33.70% | $31.21M | 0.65% |
BTAL | -19.21% | $367.96M | 1.43% |
XONE | -12.27% | $601.30M | 0.03% |
TBLL | -9.14% | $2.46B | 0.08% |
IVOL | -8.92% | $351.97M | 1.02% |
XHLF | -8.73% | $1.46B | 0.03% |
GBIL | -8.63% | $6.17B | 0.12% |
SPTS | -8.49% | $5.76B | 0.03% |
XBIL | -6.95% | $782.35M | 0.15% |
FXE | -6.71% | $538.39M | 0.4% |
IBTG | -6.40% | $1.88B | 0.07% |
FTSD | -5.84% | $212.45M | 0.25% |
ULST | -5.47% | $637.67M | 0.2% |
UTWO | -4.31% | $387.78M | 0.15% |
BIL | -3.87% | $46.76B | 0.1356% |
IBTF | -3.65% | $2.12B | 0.07% |
SOYB | -3.50% | $25.53M | 0.22% |
FXY | -3.38% | $842.67M | 0.4% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UNH | -14.53% | $279.41B | -40.49% | 3.05% |
HEES | -13.85% | $3.48B | +93.76% | 1.15% |
AGL | -12.31% | $1.11B | -49.62% | 0.00% |
AIFU | -12.08% | $9.78M | -95.05% | 0.00% |
LTM | -11.82% | $10.97B | -96.76% | 2.78% |
CMP | -10.78% | $821.17M | +57.46% | 0.00% |
GHG | -10.08% | $142.87M | -30.52% | 0.00% |
UUU | -9.56% | $4.86M | +36.36% | 0.00% |
UPBD | -9.50% | $1.45B | -24.11% | 6.11% |
CABO | -9.16% | $905.51M | -58.56% | 7.36% |
KELYA | -9.02% | $428.07M | -46.71% | 2.48% |
RLMD | -8.35% | $14.27M | -87.64% | 0.00% |
SPTN | -8.07% | $634.28M | -9.12% | 4.62% |
MKTX | -6.71% | $7.91B | -2.81% | 1.41% |
SHEN | -6.30% | $645.67M | -33.54% | 0.84% |
IRWD | -6.12% | $105.02M | -90.11% | 0.00% |
AVD | -6.11% | $120.33M | -52.17% | 0.72% |
CNMD | -5.79% | $1.81B | -21.36% | 1.36% |
VSA | -5.74% | $6.10M | -56.63% | 0.00% |
MAN | -5.65% | $1.99B | -44.73% | 7.20% |
Double maintains 14 strategies that include LLY - Eli Lilly & Co.